Product
Cefepime
Aliases
Cefepime Injection, Cefepime, Meropenem, or Piperacillin/Tazobactam, Maxipime, Merrem
5 clinical trials
6 indications
Indication
Hematopoietic and Lymphoid Cell NeoplasmIndication
Malignant Solid NeoplasmIndication
AspirationIndication
PneumoniaIndication
Cesarean SectionIndication
Febrile NeutropeniaClinical trial
An Investigator Initiated, Phase II Single-Center, Randomized, Open-Label, Prospective, Study To Determine The Impact Of Serial Procalcitonin On Improving Antimicrobial Stewardship And On The Efficacy, Safety, And Tolerability Of Imipenem-Cilastatin-Relebactam Plus/Minus Vancomycin Or Linezolid Versus Standard Of Care Antipseudomonal Beta-Lactams Plus/Minus Vancomycin Or Linezolid As Empiric Therapy In Febrile Neutropenic Adults With CancerStatus: Completed, Estimated PCD: 2023-10-06
Clinical trial
Antibiotic Prophylaxis in Critically Ill Patients After Suspected AspirationStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
The Impact of Cefepime and Unictam on Preventing Post-Cesarean Surgical Site InfectionsStatus: Active (not recruiting), Estimated PCD: 2023-09-15
Clinical trial
Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe PneumoniaStatus: Terminated, Estimated PCD: 2023-02-28
Clinical trial
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaStatus: Recruiting, Estimated PCD: 2026-07-01